It’s been a very busy, big and ambitious year for Bioasis Technologies Inc. (TSX-V.BTI, OTC:BIOAF, Forum) – a biopharmaceutical company focused on revolutionizing science by transporting therapeutic payloads across the blood-brain barrier and into the brain. And while much has been accomplished by this cutting-edge biotech in 2020, much more exciting news is expected in the pipeline for 2021.
In a relatively short period of time, the Company has generated real shareholder value by developing and commercializing its proprietary brain delivery technology – XB3 – to make life-saving drugs brain-penetrant and deliver those drugs at a therapeutically relevant dose.
In this must-hear end-of-year vodcast, Stockhouse Media’s Dave Jackson was joined by CEO Dr. Deborah Rathjen to talk more about the genesis of the amazing xB3 platform, its long-term investment potential, and all things Bioasis moving forward into 2021.
Podcast #47 Theralase Technologies
Podcast #46 Molori Energy Inc
Podcast #45: First Majestic Silver – Keith Neumeyer interview
Podcast #44: Wellness Lifestyles Inc
Podcast 43: Molori Energy Inc.
Dr. Guy Chamberland - Tetra Bio-Pharma
Podcast #42. Zomedica Pharmaceuticals Corp
Podcast #41: Luminor Medical Technologies
Podcast #40: PyroGensis Canada
Podcast: #39 Alexandria Minerals
Podcast #38: Canabo Medical
Podcast #37: Deveron UAV
Podcast #36: Vulcan Minerals
Podcast #35: Coro Mining
Dr. Kal Kotecha interviews Peter Clausi
Podcast #34: Brazil Resources
Skyharbour Interview | Mines and Money Podcast
Dr. Kal Kotecha interviews Doug MacQuarrie, CEO at Asante Gold
Dr. Kal Kotecha interviews David Morgan of the Morgan Report
Podcast #33: Neo Lithium
Create your
podcast in
minutes
It is Free
The Commercial Edge: Unleash the Power of People
The emPOWERed Half Hour
Aligned Money Show
Dubai Property Podcast
IBKR Podcasts
The Ramsey Show
The Clark Howard Podcast